News Sentiment

TXMD sentiment intelligence

TherapeuticsMD Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 48 Balanced news tone 38 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 2.00 Week of 10 Jul 2026
Weighted tone 48/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

88/100 classification confidence.

Company focus 38

directly relevant articles

Source quality 9

high-authority source matches

Trend context Trend inactive

-5.2% over one week, -9.1% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Negative

TherapeuticsMD Inc. stock underperforms Monday when compared to competitors

Market Reaction

Price moving ahead of tone

63/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 88/100 classification
One-week reaction -5.2% Price reacting lower
Trend fit Trend inactive -9.1% over four weeks
Fair value 6.8% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 9
Neutral 22
Negative 7

Relevance

Why the article matched

Direct first
Direct company coverage 38
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
MarketWatch 8
TradingKey 8
dars.gov.et 5
TradingView 4
Stock Titan 2
Moomoo 1
Simply Wall Street 1
DonanımHaber 1

Event Lens

What the news is about

Classified themes
Market update 30
Earnings 5
Deals and strategy 1
Guidance 1
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 38
MarketWatch Direct company coverage

TherapeuticsMD Inc. stock underperforms Monday when compared to competitors

TherapeuticsMD Inc. (TXMD) stock fell 1.50% to $1.97 on Monday, underperforming the broader market. Both the NASDAQ Composite Index and Dow Jones Industrial Average also experienced declines. This marks the second consecutive day of losses for TherapeuticsMD Inc. shares.

Tone
Negative 29/100
Event
Market update
Published
13 Jul 2026 23:38
Source
MarketWatch
MarketWatch Direct company coverage

TherapeuticsMD Inc. stock outperforms competitors on strong trading day

Shares of TherapeuticsMD Inc. (TXMD) rallied 2.03% to $2.01 on Thursday, outperforming the broader market. The NASDAQ Composite Index and the Dow Jones Industrial Average also saw gains. The stock closed 31.86% below its 52-week high.

Tone
Positive 75/100
Event
Market update
Published
09 Jul 2026 17:28
Source
MarketWatch
Moomoo Direct company coverage

TherapeuticsMD (TXMD) News Flow

This article provides an analysis of recent news and press releases concerning TherapeuticsMD (TXMD), focusing on how this information might impact stock performance and investor sentiment. It highlights key developments that could be relevant for current or prospective sharehold

Tone
Neutral 50/100
Event
Market update
Published
08 Jul 2026 10:11
Source
Moomoo
MarketWatch Direct company coverage

TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors

TherapeuticsMD Inc. (TXMD) shares fell by 2.31% on Thursday, closing at $2.11. This underperformance occurred on a mixed trading day, with the Dow Jones Industrial Average rising and the NASDAQ Composite Index falling. This marks the third consecutive day of losses for the stock.

Tone
Negative 20/100
Event
Market update
Published
02 Jul 2026 17:27
Source
MarketWatch
MarketWatch Direct company coverage

TherapeuticsMD Inc. stock underperforms Wednesday when compared to competitors

TherapeuticsMD Inc. (TXMD) shares fell by 2.26% on Wednesday, closing at $2.16, underperforming a broadly negative market day where the NASDAQ Composite and Dow Jones Industrial Average also declined. This marked the stock's second consecutive day of losses.

Tone
Negative 29/100
Event
Market update
Published
01 Jul 2026 17:29
Source
MarketWatch
Simply Wall Street Direct company coverage

TherapeuticsMD (Nasdaq:TXMD) - Stock Analysis

This Simply Wall St analysis of TherapeuticsMD (Nasdaq:TXMD) provides a detailed overview of the company's financial health, performance, and risks. The report highlights that TXMD is trading significantly below its estimated fair value but notes issues such as large one-off fina

Tone
Negative 38/100
Event
Market update
Published
01 Jul 2026 08:10
Source
Simply Wall Street
MarketWatch Direct company coverage

TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors

TherapeuticsMD Inc. (TXMD) stock fell 1.34% on Tuesday, closing at $2.21, despite an overall positive day for the stock market. This decline broke a four-day winning streak for the company's shares. The NASDAQ Composite Index and Dow Jones Industrial Average both saw gains on the

Tone
Negative 40/100
Event
Market update
Published
30 Jun 2026 17:30
Source
MarketWatch
MarketWatch Direct company coverage

TherapeuticsMD Inc. stock underperforms Friday when compared to competitors despite daily gains

TherapeuticsMD Inc. (TXMD) stock advanced 3.94% on Friday to $2.11, marking its third consecutive day of gains. Despite this rise, the stock underperformed compared to its competitors, as both the NASDAQ Composite Index and Dow Jones Industrial Average experienced declines. The i

Tone
Positive 59/100
Event
Market update
Published
26 Jun 2026 21:09
Source
MarketWatch
TradingView Direct company coverage

Price to book forward of TherapeuticsMD, Inc. – NASDAQ:TXMD

This article provides financial data for TherapeuticsMD, Inc. (NASDAQ: TXMD), specifically focusing on its forward price-to-book ratio. The content appears to be a stub or a data lookup result from TradingView, indicating that specific metrics for the company are available. It do

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 06:09
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of TherapeuticsMD, Inc. – NASDAQ:TXMD

This article displays the "Price to earnings forward" metric for TherapeuticsMD, Inc. (NASDAQ: TXMD). It appears to be a financial data page from TradingView, showing the company's ticker, market status, and providing navigation to various financial and community features, but th

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 05:40
Source
TradingView
TradingView Direct company coverage

Enterprise value to revenue forward of TherapeuticsMD, Inc. – NASDAQ:TXMD

This article focuses on the enterprise value to revenue forward ratio for TherapeuticsMD, Inc. (NASDAQ: TXMD). It appears to be a financial snapshot or data point from TradingView, indicating a specific financial metric for the company. The content itself seems to be a data point

Tone
Neutral 50/100
Event
Earnings
Published
24 Jun 2026 22:10
Source
TradingView
TradingKey Direct company coverage

TherapeuticsMD Inc (TXMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of TherapeuticsMD Inc (TXMD), focusing on its price momentum, support and resistance levels, and various technical indicators and moving averages. The stock currently has a price momentum score of 7.17 and is trading within a range of $1

Tone
Positive 61/100
Event
Market update
Published
24 Jun 2026 05:09
Source
TradingKey
TradingKey Direct company coverage

TherapeuticsMD Inc (TXMD) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for TherapeuticsMD Inc (TXMD), detailing its current risk score of 1.71, ranking 143 out of 157 in the Pharmaceuticals industry. Key metrics such as beta value, volatility, maximum drawdown, and Sharpe Ratio are presented to give insights i

Tone
Negative 40/100
Event
Market update
Published
23 Jun 2026 03:39
Source
TradingKey
MarketWatch Direct company coverage

TherapeuticsMD Inc. stock underperforms Monday when compared to competitors despite daily gains

TherapeuticsMD Inc. (TXMD) saw its stock rise 2.56% to $2.00 on Monday, ending a two-day losing streak. This performance occurred during a mixed trading session, with the Dow Jones Industrial Average gaining and the NASDAQ Composite Index falling. Despite its daily gains, the sto

Tone
Negative 28/100
Event
Market update
Published
22 Jun 2026 17:31
Source
MarketWatch
TradingKey Direct company coverage

TherapeuticsMD Inc (TXMD) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of TherapeuticsMD Inc (TXMD), noting its current valuation score of 7.83, which ranks it 119 out of 157 in the Pharmaceuticals industry. The company's P/E ratio stands at 125.32, indicating it is 17.44% below its recent high and 135.70%

Tone
Neutral 50/100
Event
Market update
Published
19 Jun 2026 04:40
Source
TradingKey
TradingKey Direct company coverage

TherapeuticsMD Inc (TXMD) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for TherapeuticsMD Inc (TXMD), noting that no earnings forecast score is currently available for the company, unlike the pharmaceuticals industry average of 7.84. It highlights key financial indicators like Market Cap and P/E TTM, and st

Tone
Neutral 50/100
Event
Earnings
Published
19 Jun 2026 04:40
Source
TradingKey
TradingKey Direct company coverage

TherapeuticsMD Inc (TXMD) Financial Health: Profitability & Balance Sheet Analysis

This article analyzes the financial health of TherapeuticsMD Inc (TXMD), noting its stable financial status and high operating efficiency. The company's financial score is 8.57, ranking 46th in the Pharmaceuticals industry. TherapeuticsMD reported significant year-over-year incre

Tone
Positive 72/100
Event
Market update
Published
19 Jun 2026 03:10
Source
TradingKey
TradingKey Direct company coverage

TherapeuticsMD Inc (TXMD) Institutional Confidence

TherapeuticsMD Inc (TXMD) has an institutional shareholding score of 3.00, placing it 94th out of 157 in the Pharmaceuticals industry. The latest institutional shareholding proportion is 32.99%, marking a 14.39% quarter-over-quarter increase. James Simons is the largest instituti

Tone
Neutral 50/100
Event
Market update
Published
19 Jun 2026 01:40
Source
TradingKey
TradingKey Direct company coverage

TherapeuticsMD Inc (TXMD) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of TherapeuticsMD Inc's (TXMD) dividend and stock split history. It notes that the company has distributed no dividends in the past five years and details a 50-to-1 merger-related stock split that occurred on May 6, 2022. The page also displays c

Tone
Neutral 50/100
Event
Deals and strategy
Published
17 Jun 2026 16:10
Source
TradingKey
TradingKey Direct company coverage

TherapeuticsMD Inc (TXMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for TherapeuticsMD Inc (TXMD), focusing on its regional revenue contributions. As of the updated data on April 6, the company's revenue distribution shows the United States contributing 57.14% and Non-U.S. regions contributing 42.86%. The

Tone
Neutral 50/100
Event
Earnings
Published
17 Jun 2026 16:10
Source
TradingKey
MarketWatch Direct company coverage

TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors despite daily gains

Shares of TherapeuticsMD Inc. (TXMD) rose 1.52% to $2.00 on Thursday, breaking a three-day losing streak, despite the broader market seeing a mixed performance. The Dow Jones Industrial Average gained 1.73%, while the NASDAQ Composite Index fell 0.09%. This performance still mark

Tone
Neutral 50/100
Event
Market update
Published
04 Jun 2026 17:31
Source
MarketWatch